Recursion Pharmaceuticals Inc is trading 5.3% down today at $3.15 as a broad risk-off move pressures growth and technology shares.

  • The decline gives back a portion of last week's significant gains following a post-earnings rebound.
  • The move occurs on no fresh company-specific news, appearing tied to a wider slide in AI-related stocks and speculative names.
  • Renewed higher-for-longer interest rate concerns are weighing on major U.S. indices and high-growth sectors.